Discovery of a novel class of phosphodiesterase 10A inhibitors and identification of clinical candidate 2-[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the treatment of schizophrenia.

Autor: Verhoest PR; Neuroscience, Pfizer Global Research and Development, Eastern Point Road, Groton, CT 06340, USA. patrick.r.verhoest@pfizer.com, Chapin DS, Corman M, Fonseca K, Harms JF, Hou X, Marr ES, Menniti FS, Nelson F, O'Connor R, Pandit J, Proulx-Lafrance C, Schmidt AW, Schmidt CJ, Suiciak JA, Liras S

Publikováno v: Journal of medicinal chemistry [J Med Chem] 2009 Aug 27; Vol. 52 (16), pp. 5188-96.

Brain PET measurement of PDE10A occupancy by TAK-063, a new PDE10A inhibitor, using [¹¹C]T-773 in nonhuman primates.

Autor: Takano, Akihiro, Stepanov, Vladimir, Nakao, Ryuji, Amini, Nahid, Gulyás, Balázs, Kimura, Haruhide, Halldin, Christer

Publikováno v: Synapse; Jun2016, Vol. 70 Issue 6, p253-263, 12p

Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes.

Autor: Froestl, Wolfgang, Muhs, Andreas, Pfeifer, Andrea

Publikováno v: Journal of Alzheimer's Disease; 2013, Vol. 33 Issue 3, p547-658, 112p

Cellular pathology changes in rat skin following intradermal injection of nerve growth factor: neutrophil-dependent and -independent events.

Autor: Foster, Paul A., Wicks, Sharon, Foster, Martyn, Brain, Susan D.

Publikováno v: Journal of Pathology; 2002, Vol. 197 Issue 2, p245-255, 11p

Local and cortical effects of olfactory bulb lesions on trophic support and cholinergic function and their modulation by estrogen.

Autor: Sohrabji, Farida, Peeples, Kyle W., Marroquin, Olga A.

Publikováno v: Journal of Neurobiology; 2000, Vol. 45 Issue 2, p61-74, 14p